fluphenazine and olanzapine

fluphenazine has been researched along with olanzapine in 36 studies

Research

Studies (36)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (5.56)	18.2507
2000's	24 (66.67)	29.6817
2010's	8 (22.22)	24.3611
2020's	2 (5.56)	2.80

Authors

Authors	Studies
Choudhary, MS; Craigo, SC; Meltzer, HY; Monsma, FJ; Roth, BL; Shen, Y; Sibley, DR; Uluer, A	1
Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S	1
Andaluz, B; Buschmann, H; Codony, X; Cubí, R; Díaz, JL; Dordal, A; Guitart, X; Hernández, E; Hernández, S; Holenz, J; Mas, J; Mercè, R; Monroy, X; Pérez, R; Romero, G; Sánchez, E; Sanfeliu, O; Torrens, A	1
Herrick-Davis, K; Purohit, A; Smith, C; Teitler, M	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bailey, RK; Dralle, PW; Eschmann, AJ; Strauss, AJ; Wagner, RB	1
Miledi, R; Nguyen, QT; Yang, J	1
Bilici, M; Cakirbay, H; Guler, M; Tan, U; Tosun, M; Ulgen, M	1
Conley, RR; Kelly, DL; Love, RC; McMahon, RP	1
Andersen, J; Duncan, E; Dunlop, BW; Phillips, LS; Sternberg, M	1
Ahmed, B; Tofler, IT	1
Dossenbach, MR; Folnegovic-Smalc, V; Friedel, P; Grundy, SL; Hotujac, L; Jakovljevic, MM; Tollefson, GD; Uglesic, B	1
Kozaric-Kovacic, D; Muck-Seler, D; Pivac, N	1
Broll, K; Hess, L; Ibach, B; Perfahl, M; Pfeiff, L; Putzhammer, A	1
Barna, I; Gazdag, G; Iványi, Z; Tolna, J	1
Dwyer, DS; Lu, XH	1
Baldessarini, RJ; Gan, L; Moran-Gates, T; Park, YS; Tarazi, FI; Zhang, K	1
Charles, J; Miller, G; Ng, A	1
Alvir, D; Kondić, L; Matijević, V; Supe, S	1
Arellano, A; Baptista, T; Beaulieu, S; Contreras, Q; Galeazzi, T; Hernández, L; Lacruz, A; Martinez, M; Mendoza, S; Vargas, D	1
Jakovljevic, M; Ljubicic, D; Marcinko, D; Mihaljevic-Peles, A; Muck-Seler, D; Mustapic, M; Pivac, N; Relja, M	1
Boshoven, W; Duncan, E; Dunlop, BW; Hamer, RM; Phillips, LS; Woolson, SL	1
Alfirevic, Z; Degoricija, V; Vucicevic, Z; Vukicevic-Badouin, D	1
Dembler, T; Gallinat, J; Heinz, A; Juckel, G; Kahnt, T; Kienast, T; Knutson, B; Koslowski, M; Schlagenhauf, F; Wrase, J	1
Duggal, HS; Singh, I	1
Aamodt, EJ; Donohoe, DR; Dwyer, DS; Phan, T; Weeks, K	1
Czernikiewicz, A; Kucharska-Pietura, K; Mortimer, A; Tylec, A	1
Chrisphonte, P; Ostroff, RB; Rosenheck, RA	1
Kirk Morton, N; Zubek, D	1
Furtado, VA; Li, BG; Sampford, JR; Sampson, S; Xia, J; Zhao, S	1
Dubin, WR; Fu, E; Kovach, JG	1
Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G	1
Osman, E; Yıldız, M	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1

Reviews

3 review(s) available for fluphenazine and olanzapine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews, 2016, Jul-02, Volume: 7 Topics: Administration, Oral; Amisulpride; Antipsychotic Agents; Benzodiazepines; Fluphenazine; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome	2016
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis. The American journal of psychiatry, 2021, 05-01, Volume: 178, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention	2021

Trials

6 trial(s) available for fluphenazine and olanzapine

Article	Year
Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. The International journal of neuroscience, 2002, Volume: 112, Issue:7 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Bone Density; Clopenthixol; Clozapine; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia	2002
Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:2 Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Female; Fluphenazine; Humans; Longitudinal Studies; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Treatment Outcome	2004
Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder. Psychopharmacology, 2004, Volume: 175, Issue:4 Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Dose-Response Relationship, Drug; Fluphenazine; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Stress Disorders, Post-Traumatic	2004
[Alterations of gait parameters under external cueing in schizophrenic patients: a switch study]. Psychiatrische Praxis, 2004, Volume: 31 Suppl 1 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Exercise Test; Female; Flupenthixol; Fluphenazine; Gait; Haloperidol; Humans; Male; Middle Aged; Muscle Rigidity; Olanzapine; Schizophrenia	2004
Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia. Schizophrenia research, 2007, Volume: 89, Issue:1-3 Topics: Adult; Antipsychotic Agents; Appetite; Benzodiazepines; Blood Glucose; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Humans; Insulin; Insulin Resistance; Male; Olanzapine; Reference Values; Risperidone; Schizophrenia; Weight Gain	2007
The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Mar-30, Volume: 31, Issue:2 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Female; Fluphenazine; Humans; Hydrocortisone; Muscle Rigidity; Olanzapine; Prolactin; Schizophrenia	2007

Other Studies

27 other study(ies) available for fluphenazine and olanzapine

Article	Year
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:3 Topics: Animals; Antipsychotic Agents; Cell Line; Molecular Structure; Rats; Receptors, Serotonin	1994
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:3 Topics: Animals; Antipsychotic Agents; Discriminant Analysis; Drug Evaluation, Preclinical; Forecasting; Humans; Protein Binding; Receptors, Histamine H1; Statistics, Nonparametric; Weight Gain	2003
Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands. Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6 Topics: Adenylyl Cyclases; Benzoxazines; Cell Line; Humans; Indoles; Ligands; Piperidines; Radioligand Assay; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Sulfonamides	2005
Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs. Psychopharmacology, 2005, Volume: 179, Issue:2 Topics: Amino Acid Substitution; Antipsychotic Agents; Cell Line; Cyclic AMP; Humans; Mutagenesis, Site-Directed; Mutation; Radioligand Assay; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Conventional psychotropic-induced tremor extinguished by olanzapine. The American journal of psychiatry, 1998, Volume: 155, Issue:8 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Fluphenazine; Haloperidol; Humans; Male; Mental Disorders; Olanzapine; Pirenzepine; Tremor	1998
Effects of atypical antipsychotics on vertebrate neuromuscular transmission. Neuropharmacology, 2002, Volume: 42, Issue:5 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Fluphenazine; In Vitro Techniques; Membrane Potentials; Motor Endplate; Neuromuscular Junction; Olanzapine; Pirenzepine; Rana pipiens; Rana temporaria; Risperidone; Sulpiride; Synaptic Transmission	2002
Rehospitalization risk with second-generation and depot antipsychotics. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2003, Volume: 15, Issue:1 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Data Collection; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Patient Readmission; Pirenzepine; Risperidone; Schizophrenia; Secondary Prevention; Time Factors; Treatment Outcome	2003
Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics. Psychopharmacology bulletin, 2003,Summer, Volume: 37, Issue:3 Topics: Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Cohort Studies; Depressive Disorder; Diabetes Mellitus; Female; Fluphenazine; Glucose; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Retrospective Studies	2003
Atypical (olanzapine) plus conventional (fluphenazine) neuroleptic treatment associated with the neuroleptic malignant syndrome. Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:6 Topics: Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Fluphenazine; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine	2003
The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy. Ideggyogyaszati szemle, 2004, Nov-20, Volume: 57, Issue:11-12 Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Brain; Clopenthixol; Clozapine; Dibenzothiazepines; Electric Impedance; Electroconvulsive Therapy; Electroencephalography; Electromyography; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Seizures; Sulpiride	2004
Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK, and pertussis toxin-sensitive pathways. Journal of molecular neuroscience : MN, 2005, Volume: 27, Issue:1 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Chromones; Clozapine; Dibenzothiazepines; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Fluphenazine; Haloperidol; Humans; Morpholines; Nerve Growth Factor; Neurites; Olanzapine; PC12 Cells; Pertussis Toxin; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quetiapine Fumarate; Rats	2005
Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects. Synapse (New York, N.Y.), 2006, Volume: 59, Issue:2 Topics: Age Factors; Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Clozapine; Fluphenazine; Image Processing, Computer-Assisted; Male; Olanzapine; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, Dopamine	2006
Management of psychosis in Australian general practice. Australian family physician, 2006, Volume: 35, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Antimanic Agents; Antipsychotic Agents; Australia; Benzodiazepines; Directive Counseling; Female; Fluphenazine; Humans; Lithium Carbonate; Male; Middle Aged; Olanzapine; Psychotic Disorders; Referral and Consultation; Sex Factors	2006
Series of seizures as a sign of development of recurrent malignant neuroleptic syndrome - a case report. Psychiatria Danubina, 2006, Volume: 18, Issue:1-2 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Drug Therapy, Combination; Early Diagnosis; Electroencephalography; Epilepsy, Generalized; Fluphenazine; Humans; Male; Neuroleptic Malignant Syndrome; Olanzapine; Recurrence; Risk Factors; Schizophrenia; Seizures	2006
Relative risk of glucose elevation during antipsychotic exposure in a Veterans Administration population. International clinical psychopharmacology, 2007, Volume: 22, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Blood Glucose; Chlorpromazine; Cohort Studies; Female; Fluphenazine; Haloperidol; Hospitals, Veterans; Humans; Hyperglycemia; Incidence; Male; Middle Aged; Olanzapine; Perphenazine; Retrospective Studies; Risk Assessment; Risk Factors; Risperidone; Southeastern United States; Time Factors; Veterans	2007
Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy. International journal of clinical pharmacology and therapeutics, 2007, Volume: 45, Issue:5 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain Edema; Fatal Outcome; Fluphenazine; Haloperidol; Heart Arrest; Humans; Hyperglycemia; Hyponatremia; Inappropriate ADH Syndrome; Male; Mental Disorders; Olanzapine; Pancreatitis; Paroxetine; Polypharmacy; Selective Serotonin Reuptake Inhibitors	2007
Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology, 2008, Volume: 196, Issue:4 Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dopamine D2 Receptor Antagonists; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Motivation; Neostriatum; Nucleus Accumbens; Olanzapine; Oxygen; Psychomotor Performance; Reaction Time; Receptors, Dopamine D2; Reward; Schizophrenia; Schizophrenic Psychology	2008
Neuroleptic malignant syndrome presenting with acute renal failure. Progress in neuro-psychopharmacology & biological psychiatry, 2008, May-15, Volume: 32, Issue:4 Topics: Acute Kidney Injury; Antipsychotic Agents; Benzodiazepines; Electroencephalography; Female; Fluphenazine; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Psychotic Disorders	2008
Antipsychotic drugs up-regulate tryptophan hydroxylase in ADF neurons of Caenorhabditis elegans: role of calcium-calmodulin-dependent protein kinase II and transient receptor potential vanilloid channel. Journal of neuroscience research, 2008, Aug-15, Volume: 86, Issue:11 Topics: Adaptation, Physiological; Animals; Animals, Genetically Modified; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Chloride Channels; Clozapine; Fluphenazine; Microscopy, Fluorescence; Neurons; Olanzapine; Receptors, Serotonin, 5-HT2; Serotonin; Trifluoperazine; TRPV Cation Channels; Tryptophan Hydroxylase; Up-Regulation	2008
Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs. Medical science monitor : international medical journal of experimental and clinical research, 2012, Volume: 18, Issue:1 Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Attention; Benzodiazepines; Dibenzothiazepines; Emotions; Fluphenazine; Haloperidol; Humans; Memory; Middle Aged; Olanzapine; Perazine; Perphenazine; Quetiapine Fumarate; Recognition, Psychology; Risperidone; Schizophrenia; Sulpiride	2012
Perphenazine suspension: a new, old treatment, side effects and continuous use. The Psychiatric quarterly, 2012, Volume: 83, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cholinergic Antagonists; Clinical Trials as Topic; Drug Compounding; Drug Delivery Systems; Female; Fluphenazine; Haloperidol; Hospitals, Psychiatric; Humans; Male; Movement Disorders; Olanzapine; Patient Discharge; Perphenazine; Risperidone; Suspensions; Treatment Outcome	2012
Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia. Journal of psychosocial nursing and mental health services, 2013, Volume: 51, Issue:3 Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia	2013
Priapism Associated With Antipsychotic Medication Use: Case Report. Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:4 Topics: Antipsychotic Agents; Fluphenazine; Humans; Male; Middle Aged; Olanzapine; Priapism; Risperidone	2017
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2022,Summer, Volume: 33, Issue:2 Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine	2022
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013